CN Patent

CN110294800B — 一种索玛鲁肽的制备方法

Assigned to Qilu Pharmaceutical Co Ltd · Expires 2022-03-04 · 4y expired

What this patent protects

本发明属于多肽合成领域，特别涉及一种新的索玛鲁肽的制备方法，既能减少杂质的产生，尤其是[D‑His 1 ]‑索玛鲁肽，又可提高产率，降低生产成本，可用于工业上大规模生产索玛鲁肽。

USPTO Abstract

本发明属于多肽合成领域，特别涉及一种新的索玛鲁肽的制备方法，既能减少杂质的产生，尤其是[D‑His 1 ]‑索玛鲁肽，又可提高产率，降低生产成本，可用于工业上大规模生产索玛鲁肽。

Drugs covered by this patent

Patent Metadata

Patent number
CN110294800B
Jurisdiction
CN
Classification
—
Expires
2022-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Qilu Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.